Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

  title={Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study},
  author={Benjamin F. Voight and Gina M. Peloso and Marju Orho-Melander and Ruth Frikke-Schmidt and Maja Barbali{\'c} and Majken K. Jensen and George Hindy and Hilma H{\'o}lm and Eric L. Ding and Toby Johnson and Heribert Schunkert and Nilesh J. Samani and Robert J. Clarke and Jemma C. Hopewell and John F. Thompson and Mingyao Li and Gudmar Thorleifsson and Christopher Newton-Cheh and Kiran Musunuru and James P. Pirruccello and Danish Saleheen and Li Chen and Alexandre F. R. Stewart and Arne Schillert and Unnur Thorsteinsd{\'o}ttir and Gudmundur Thorgeirsson and Sonia S Anand and James C. Engert and T M Morgan and John A. Spertus and Monika Stoll and Klaus Berger and Nicola Martinelli and Domenico Girelli and Pascal P. McKeown and Christopher C. Patterson and Stephen E. Epstein and Joseph M. Devaney and Mary Susan Burnett and Vincent Mooser and Samuli Ripatti and Ida Surakka and Markku S Nieminen and Juha P. Sinisalo and Marja-Liisa Lokki and Markus Perola and Aki Samuli Havulinna and Ulf de Faire and Bruna Gigante and Erik Ingelsson and Tanja Zeller and Philipp S. Wild and Paul I. W. de Bakker and Olaf H. Klungel and Anke H. Maitland‐van der Zee and Bas J. M. Peters and Anthonius de Boer and Diederick E. Grobbee and Pieter Willem Kamphuisen and Vera H M Deneer and Clara C Elbers and N. Charlotte Onland-Moret and Marten H. Hofker and Cisca Wijmenga and W. M. Monique Verschuren and Jolanda M.A. Boer and Yvonne T. van der Schouw and Asif Rasheed and P. M. Frossard and Serkalem Demissie and Cristen J. Willer and Ron Do and Jos{\'e} M. Ordov{\'a}s and Gonçalo R. Abecasis and Michael Boehnke and Karen L. Mohlke and Mark J. Daly and Candace Guiducci and Noël P. Burtt and Aarti Surti and Elena Gonzalez and Shaun M Purcell and S. Gabriel and Jaume Marrugat and John F. Peden and Jeanette Erdmann and Patrick (formerly Linsel-Nitschke) Diemert and Christina Willenborg and Inke Regina K{\"o}nig and Marcus M. Fischer and Christian Hengstenberg and Andreas Ziegler and Ian Buysschaert and Diether Lambrechts and Frans Van de Werf and Keith A. A. Fox and Nour Eddine El Mokhtari and Diana Rubin and J{\"u}rgen Schrezenmeir and Stefan Schreiber and Arne S Sch{\"a}fer and John Danesh and Stefan Blankenberg and Robert Roberts and Ruth McPherson and Hugh C. Watkins and Alistair S. Hall and Kim Overvad and Eric B. Rimm and Eric Boerwinkle and Anne Tybjaerg-hansen and L. Adrienne Cupples and Muredach P. Reilly and Olle Melander and Pier Mannuccio Mannucci and Diego Ardissino and David S. Siscovick and Roberto Elos{\'u}a and K{\'a}ri Stef{\'a}nsson and Christopher J. O’Donnell and Veikko V Salomaa and Daniel J. Rader and Leena Peltonen and Stephen M. Schwartz and David M Altshuler and Sekar Kathiresan},
  pages={572 - 580}

Figures and Tables from this paper

Mendelian randomization of blood lipids for coronary heart disease

The genetic findings support a causal effect of triglycerides on CHD risk, but a causal role for HDL-C, though possible, remains less certain.

Plasma HDL cholesterol and risk of dementia - observational and genetic studies.

High plasma HDL cholesterol was observationally associated with increased risk of any dementia and Alzheimer's disease, suggesting that HDL cholesterol can be used as an easily accessible plasma biomarker for individual risk assessment.

Differential Effects of Genetically Determined Cholesterol Efflux Capacity on Coronary Artery Disease and Ischemic Stroke

Genetic predicted higher CEC may be associated with decreased risk of CAD, and the casual association of CEC with ischemic stroke and specific subtypes would need to be validated in further Mendelian randomization studies.

Lipid Fractions and Contrasting Risks of Coronary Artery Disease and Diabetes: A Mendelian Randomization Study

Routinely measured lipid fractions exhibit contrasting relationships with risk of CAD and diabetes, and increased LDL-C, HDL-C and TG are associated with reduced risk of diabetes.

Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction.

Data from the Copenhagen City Heart Study are consistent with a causal association between elevated levels of remnant cholesterol in hypertriglyceridaemia and an increased risk of myocardial infarction.

Using Multivariable Mendelian Randomization to Disentangle the Causal Effects of Lipid Fractions

It is suggested that HDL-c may be causally protective of CAD risk, independently of the effects of LDL-c and triglyceride, and genetic predictors of LDL, HDL, and triglycerides each have independent associations with CAD risk.



Polymorphisms associated with cholesterol and risk of cardiovascular events.

A genotype score of nine validated SNPs that are associated with modulation in levels of LDL or HDL cholesterol was an independent risk factor for incident cardiovascular disease.

Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease.

Lower plasma levels of HDL cholesterol due to heterozygosity for loss-of-function mutations in ABCA1 were not associated with an increased risk of ischemic heart disease, and the association between IHD and HDL cholesterol and genotype was unclear.

Genetic variants associated with Lp(a) lipoprotein level and coronary disease.

Two LPA variants were strongly associated with both an increased level of Lp(a) lipoprotein and an increased risk of coronary disease, and the association between the LPA genotype score and the risk of heart disease was abolished.

Hepatic lipase, genetically elevated high-density lipoprotein, and risk of ischemic cardiovascular disease.

Hematic lipase genetic variants with elevated levels of HDL cholesterol did not associate with risk of ICD and was higher in heterozygotes, as compared with noncarriers.

Identification of Genetic Variants in Endothelial Lipase in Persons With Elevated High-Density Lipoprotein Cholesterol

Six new potentially functional variants in EL were discovered through sequencing of the EL gene in subjects with high HDL-C levels, and restrictions enzyme analysis confirmed six of these were potentially functional and were confirmed by restriction enzyme analysis.

Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids

The results identify several novel loci associated with plasma lipids that are also associated with CAD and provide the foundation to develop a broader biological understanding of lipoprotein metabolism and to identify new therapeutic opportunities for the prevention of CAD.

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.

It is indicated that moderate lifelong reduction in the plasma level of LDL cholesterol is associated with a substantial Reduction in the incidence of coronary events, even in populations with a high prevalence of non-lipid-related cardiovascular risk factors.

Genomewide association analysis of coronary artery disease.

Several genetic loci that, individually and in aggregate, substantially affect the risk of development of coronary artery disease are identified.

Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease.

  • N. Mehta
  • Biology
    Circulation. Cardiovascular genetics
  • 2011
The analysis of approximately 135 000 individuals more than doubled the number of loci with CAD association, yielding 13 previously unidentified loci and confirming at least 13 previously undisclosed loci in genome-wide association studies of CAD and MI.

A variant at chromosome 9p21 is associated with recurrent myocardial infarction and cardiac death after acute coronary syndrome: the GRACE Genetics Study.

In this large observational study, the 9p21 variant was independently associated with adverse cardiac outcome after ACS and inclusion of rs1333049 into the GRACE risk score significantly improved classification for recurrent MI or cardiac death, as calculated by the integrated discrimination improvement method.